Mirror-Image Molecule Targets Cancer Cells, Spares Healthy Tissues
Scientists discover a mirror-image amino acid that starves cancer cells in preclinical studies, offering hope for targeted therapies with fewer side effects. Reported by BioMedWire.
This discovery could lead to cancer treatments with fewer side effects, improving patient quality of life and therapy adherence. It represents a shift toward precision medicine in oncology, potentially making treatments more effective and tolerable for millions affected by cancer worldwide.
